Differential involvement of TGF-β1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells

Experimental Cell Research

Volumn 314, Issue 13, 2008, Pages 2323-2333

  Motegi, Katsumi ^a,b   Harada, Koji ^a,b   Ohe, Go ^a,b   Jones, Sarah J ^a   Ellis, Ian R ^a   Crouch, Dorothy H ^c   Schor, Seth L ^a   Schor, Ana M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Endothelial cells; FGF 2; Fibroblasts; Migration; Oral tumour cells; TGF 1; TSP 1; v 3

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; NEUTRALIZING ANTIBODY; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MOUTH TUMOR; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL LINE;

BOVINAE;

EID: 47349134003     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.04.013     Document Type: Article

References (79)

1. Chen H., Herndon M.E., and Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 19 (2000) 597-614
2. Esemuede N., Lee T., Pierre-Paul D., Sumpio B.E., and Gahtan V. The role of thrombospondin-1 in human disease. J. Surg. Res. 122 (2004) 135-142
3. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell. Mol. Med. 6 (2002) 1-12
4. Ren B., Yee K.O., Lawler J., and Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim. Biophys. Acta, Rev. on cancer 1765 (2006) 178-188
5. Sargiannidou I., Zhou J., and Tuszynski G.P. The role of thrombospondin-1 in tumor progression. Exp. Biol. Med. 226 (2001) 726-733
6. Sid B., Sartelet H., Bellon G., El Btaouri H., Rath G., Delorme N., Haye B., and Martiny L. Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Crit. Rev. Oncol. Hemat. 49 (2004) 245-258
7. Motegi K., Harada K., Pazouki S., Baillie R., and Schor A.M. Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis. Histochem. J. 34 (2002) 411-421
8. Yao L., Zhao Y.L., Itoh S., Wada S., Yue L., and Furuta I. Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival. Oral oncol. 36 (2000) 539-544
9. Hayashido Y., Nakashima M., Urabe K., Yoshioka H., Yoshioka Y., Hamana T., Kitano H., Koizumi K., and Okamoto T. Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells. Int. J. Mol. Med. 12 (2003) 447-452
10. Macluskey M., Baillie R., Morrow H., Schor S.L., and Schor A.M. Extraction of RNA from archival tissues and measurement of thrombospondin-1 mRNA in normal, dysplastic and malignant oral tissues. Br. J. Oral Max. Surg. 44 (2006) 116-123
11. Albo D., Berger D.H., Vogel J., and Tuszynski G.P. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type I in pancreatic cancer. J. Gastrointest. Surg. 3 (1999) 411-417
12. Albo D., Shinohara T., and Tuszynski G.P. Upregulation of matrix metalloproteinase-9 by thrombospondin-1 in gastric cancer. J. Surg. Res. 108 (2002) 51-60
13. Rodriguez-Manzaneque J.C., Lane T.F., Ortega M.A., Hynes R.O., Lawler J., and Iruela-Arispe M.L. Thrombospondin-1 suppresses tumour growth by a novel mechanism that includes blockade of matrix metalloproteinase-9 activation, and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12485-12490
14. Qian X., Wang T.N., Rothman V.L., Nicosia R.F., and Tuszynski G.P. Thrombospondin-1 regulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp. Cell Res. 235 (1997) 403-412
15. Taraboletti G., Borsotti P., Morbidelli L., Giavazzi R., and Ziche M. Thrombospondin-1 fragments with opposite effect on angiogenesis. AACR Annual Meeting 39 (1998) 304
16. Taraboletti G., Morbidelli L., Donnini S., Parenti A., Granger H.J., Giavazzi R., and Ziche M. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J. 14 (2000) 1674-1676
17. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., and Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122 (1993) 497-511
18. Lee N.V., Sato M., Annis D.S., Loo J.A., Wu L., Mosher D.F., and Iruela-Arispe M.L. ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J. 25 (2006) 5270-5283
19. Schultz-Cherry S., and Murphy-Ullrich J.E. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122 (1993) 923-932
20. Murphy-Ullrich J.E., and Poczatek M. Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11 (2000) 59-69
21. Wang T.N., Qian X.H., Granick M.S., Solomon M.P., Rothman Y.L., and Tuszynski G.P. The effects of thrombospondin on oral squamous carcinoma cell invasion of collagen. Am. J. Surg. 170 (1995) 502-505
22. Sakai K., Sumi Y., Muramatsu H., Hata K., Muramatsu T., and Ueda M. Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of transforming growth factor β-1. J. Dermatol. Sci. 31 (2003) 99-109
23. Breitkopf K., Sawitza I., Westhoff J.H., Wickert L., Dooley S., and Gressner A.M. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut 54 (2005) 673-681
24. Uchida H., Kuroki M., Shitama T., Hayashi H., and Kuroki M. Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cells. Curr. Eye Res. 33 (2008) 199-203
25. Negoescu A., Lafeuillade B., Pellerin S., Chambaz E.M., and Feige J.J. Transforming growth factors β stimulate both thrombospondin-1 and CISP/thrombospondin-2 synthesis by bovine adrenocortical cells. Exp. Cell Res. 217 (1995) 404-409
26. Okamoto M., Ono M., Uchiumi T., Ueno H., Kohno K., Sugimachi K., and Kuwano M. Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor β in human cancer cells - transcriptional activation and messenger RNA stabilization. Biochim. Biophys. Acta, Gene Struct. Expression 1574 (2002) 24-34
27. Nakagawa T., Li J.H., Garcia G., Mu W., Piek E., Böttinger E.P., Chen Y., Zhu H.J., Kang D.H., Schreiner G.F., Lan H.Y., and Johnson R.J. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int. 66 (2004) 862-863
28. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., and Tamaki K. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts. Am. J. Pathol 166 (2005) 1451-1463
29. Miyanaga K., Kato Y., Nakamura T., Matsumura M., Amaya H., Horiuchi T., Chiba Y., and Tanaka K. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res. 22 (2002) 3941-3948
30. Miao W.M., Seng W.L., Duquette M., Lawler P., Laus C., and Lawler C.J. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor β-dependent and -independent mechanisms. Cancer Res. 61 (2001) 7830-7839
31. Schor S.L. Cell proliferation and migration on collagen substrata in vitro. J. Cell Sci. 41 (1980) 159-175
32. Schor S.L., Ellis I.R., Harada K., Motegi K., Anderson A.R.A., Chaplain M.A.J., Keatch R.P., and Schor A.M. A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay. Cell Motil. Cytoskelet. 63 (2006) 287-300
33. Shirasuna K., Sato M., and Miyazaki T. A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer (Phila.) 48 (1981) 745-752
34. Shirasuna K., Watatani K., Sugiyama M., Morioka S., and Miyazaki T. Isolation and characterization of different clones including myoepithelial-like variants from a clonal neoplastic epithelial duct cell line of human salivary gland origin. Cancer Res. 46 (1986) 1418-1426
35. Yanagawa T., Hayashi Y., Yoshida H., Yura Y., Nagamine S., Bando T., and Sato M. An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. Am. J. Pathol. 124 (1986) 496-509
36. Schor A.M., Schor S.L., and Allen T.D. Effects of culture conditions on the proliferation, morphology and migration of bovine aortic endothelial cells. J. Cell Sci. 62 (1983) 267-285
37. Sutton A.B., Canfield A.E., Schor S.L., Grant M.E., and Schor A.M. The response of endothelial cells to TGF-β1 is dependent upon cell shape, proliferative state and the nature of the substratum. J. Cell Sci. 99 (1991) 777-787
38. O'Hare M.J., Bond J., Clarke C., Takeuchi Y., Atherton A.J., Berry C., Moody J., Silver A.R.J., Davies D.C., Alsop A.E., Neville A.M., and Jat P.S. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 646-651
39. Schor S.L., Ellis I., Dolman C., Banyard J., Humphries M.J., Mosher D.F., Grey A.M., Mould A.P., Sottile J., and Schor A.M. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J. Cell Sci. 109 (1996) 2581-2590
40. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47 (1987) 936-942
41. Azuma M., Aota K., Tamatani T., Motegi K., Yamashita T., Harada K., Hayashi Y., and Sato M. Supression of tumour necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells. Arthritis and Rheumatism 43 (2000) 1756-1767
42. Like B., and Massague J. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261 (1986) 13426-13429
43. Grainger D.J., and Frow E.K. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures. Biochem. J. 350 (2000) 291-298
44. Good D.J., Polverini P.J., Rastinejad F., LeBeau M.M., Lemons R.S., Frazier W.A., and Bouck N.P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6624-6628
45. Taraboletti G., Roberts D., Liotta L.A., and Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111 (1990) 765-772
46. Simantov R., Febbraio M., Crombie R., Asch A.S., Nachman R.L., and Silverstein R.L. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J. Clin. Invest. 107 (2001) 45-52
47. Dawson D.W., Pearce S.F.A., Zhong R.Q., Silverstein R.L., Frazier W.A., and Bouck N.P. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138 (1997) 707-717
48. Canfield A.E., Boot-Handford R.P., and Schor A.M. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem. J. 268 (1990) 225-230
49. Canfield A.E., Wren F.E., Schor S.L., Grant M.E., and Schor A.M. Aortic endothelial cell heterogeneity in vitro. Lack of association between morphological phenotype and collagen biosynthesis. J. Cell Sci. 102 (1992) 807-814
50. 3 integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation. J. Biol.Chem. 274 (1999) 22755-22762
51. Pardali K., and Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta Rev. cancer 1775 (2007) 21-62
52. Albo D., Berger D.H., Wang T.N., Hu X.L., Rothman V., and Tuszynski G.P. Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system. Surgery 122 (1997) 493-499
53. Albo D., Berger D.H., and Tuszynski G.P. The effect of thrombospondin-1 and TGF-β 1 on pancreatic cancer cell invasion. J. Surg. Res. 76 (1998) 86-90
54. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., and ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21 (2002) 1743-1753
55. Albo D., and Tuszynski G.P. Thrombospondin-1 up-regulates tumour cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. J. Surg. Res. 120 (2004) 21-26
56. Guo N.H., Zabrenetzky V.S., Chandrasekaran L., Sipes J.M., Lawler J., Krutzsch H.C., and Roberts D.D. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1. Cancer Res. 58 (1998) 3154-3162
57. Wang T.N., Qian X.H., Granick M.S., Solomon M.P., Rothman V.L., Berger D.H., and Tuszynski G.P. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J. Surg. Res. 63 (1996) 39-43
58. Albo D., Arnoletti J.P., Castiglioni A., Granick M.S., Solomon M.P., Rothman V.L., and Tuszynski G.P. Thrombospondin (TSP) and transforming growth factor β1 (TGF-β) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (Pal-1) production and stimulate tumor cell attachment in vitro. Biochem. Biophys. Res. Commun. 203 (1994) 857-865
59. Arnoletti J.P., Albo D., Granick M.S., Solomon M.P., Castiglioni A., Rothman V.L., and Tuszynski G.P. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast-cancer cells. Cancer 76 (1995) 998-1005
60. Yee K.O., Streit M., Hawighorst T., Detmar M., and Lawler J. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-β. Am. J. Pathol. 165 (2004) 541-552
61. Kanda S., Shono T., Tomasini-Johansson B., Klint P., and Saito Y. Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis. Exp. Cell Res. 252 (1999) 262-272
62. do Outeiro-Bernstein M.A.F., Nunes S.S., Andrade A.C.M., Alves T.R., Legrand C., and Morandi V. A recombinant NH2-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix biol. 21 (2002) 311-324
63. Nesselroth S.M., Willis A.I., Fuse S., Olson E.T., Lawler J., Sumpio B.E., and Gahtan V. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis. J. Vasc. Surg. 33 (2001) 595-600
64. 3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways. J. Biol. Chem. 271 (1996) 3247-3254
65. 3. Biochem. J. 369 (2003) 311-318
66. 3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts. J. Immunol. 175 (2005) 7708-7718
67. Lebrin F., Deckers M., Bertolino P., and ten Dijke P. TGF-β receptor function in the endothelium. Cardiovascular Res. 65 (2005) 599-608
68. Pepper M.S., Vassalli J.D., Orci L., and Montesano R. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell Res. 204 (1993) 356-363
69. Canfield A.E., and Schor A.M. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci. 108 (1995) 797-809
70. Farina A.R., Coppa A., Tiberio A., Tacconelli A., Turco A., Colletta G., Gulino A., and Mackay A.R. Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up regulating urokinase activity. Int. J. Cancer 75 (1998) 721-730
71. Schor S.L., Allen T.D., and Harrison C.J. Cell migration into 3D gels of native collagen fibres: Collagenolytic activity is not required for the migration of two permanent cell lines. J. Cell Sci. 46 (1980) 171-186
72. Schor A.M., and Schor S.L. The isolation and culture of endothelial cells and pericytes from the bovine retinal microvasculature: a comparative study with large vessel vascular cells. Microvasc. Res. 32 (1986) 21-38
73. Plouët J., and Gospodarowicz D. Transforming growth factor β-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells. J. Cell Physiol. 141 (1989) 392-399
74. Kay R.A., Ellis I.R., Jones S.J., Perrier S., Florence M.M., Schor A.M., and Schor S.L. The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3¢-untranslated region-dependent nuclear sequestration of its precursor messenger RNA. Cancer Res. 65 (2005) 10742-10749
75. Pratt D.A., Miller W.R., and Dawes J. Thrombospondin in malignant and non-malignant breast tissue. Eur. J. Cancer Clin. Oncol. 25 (1989) 343-350
76. Mehta R., Kyshtoobayeva A., Kurosaki T., Small E.J., Kim H., Stroup R., McLaren C.E., Li K.T., and Fruehauf J.P. Independent association of angiogenesis index with outcome in prostate cancer. Clin.Cancer Res. 7 (2001) 81-88
77. Kishi M., Nakamura M., Nishimine M., Ishida E., Shimada K., Kirita T., and Konishi N. Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas. Cancer Sci. 94 (2003) 530-535
78. Kasper H.U., Ebert M., Malfertheiner P., Roessner A., Kirkpatrick C.J., and Wolf H.K. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density. Virchows archiv-an international journal of pathology, 438 (2001) 116-120
79. Straume O., and Akslen L.A. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am. J. Path. 159 (2001) 223-235